September 12, 2013
Visterra Announces an Oral Presentation of VIS410 Data that Showed Neutralization
of H5 and H7 Influenza Strains with Pandemic Potential
Preclinical results presented at ICAAC 2013 demonstrated the ability of VIS410 to neutralize influenza strains with pandemic potential, H5N1 and H7N9
VIS410, a novel engineered human antibody against seasonal and pandemic flu, is advancing to the clinic in 2014
http://ca.finance.yahoo.com/news/visterra-announces-oral-presentation-vis410-230000576.html
No comments:
Post a Comment